Dr Reddys Laboratories (RDY) Invested Capital (2017 - 2026)
Dr Reddys Laboratories has reported Invested Capital over the past 10 years, most recently at $4.2 billion for Q1 2026.
- For Q1 2026, Invested Capital fell 21.25% year-over-year to $4.2 billion; the TTM value through Mar 2026 reached $4.2 billion, down 21.25%, while the annual FY2026 figure was $4.2 billion, 21.9% down from the prior year.
- Invested Capital for Q1 2026 was $4.2 billion at Dr Reddys Laboratories, down from $5.3 billion in the prior quarter.
- Over five years, Invested Capital peaked at $5.3 billion in Q1 2025 and troughed at $2.6 billion in Q1 2022.
- A 5-year average of $3.8 billion and a median of $3.6 billion in 2023 define the central range for Invested Capital.
- Biggest five-year swings in Invested Capital: surged 2570.79% in 2022 and later decreased 21.25% in 2026.
- Year by year, Invested Capital stood at $2.6 billion in 2022, then skyrocketed by 37.82% to $3.6 billion in 2023, then fell by 4.15% to $3.5 billion in 2024, then soared by 52.48% to $5.3 billion in 2025, then fell by 21.25% to $4.2 billion in 2026.
- Business Quant data shows Invested Capital for RDY at $4.2 billion in Q1 2026, $5.3 billion in Q1 2025, and $3.5 billion in Q1 2024.